What’s hot in diabetes nursing? August 2025

Medicines

Dapagliflozin for treating chronic kidney disease

Evidence-based recommendations from NICE TA1075.

(Source: NICE)

Medicine Supply Notification

Discontinuation of Novo Nordisk insulin products (NovoRapid FlexTouch, Insulatard Penfill and all Levemir presentations).

Also, guidance from ABCD and PCDO Society on managing the Levemir discontinuation to include appropriately selecting and safely prescribing alternative insulin therapy.

(Source: Dept of Health & Social Care)

Medicine Supply Notification

Discontinued Humulin and Humalog products and alternative presentations.r this year’s awards recognising innovative practice demonstrating quality in diabetes care.

(Source: Dept of Health & Social Care)

Medicine Supply Notification

Discontinued Humulin and Humalog products and alternative presentations.r this year’s awards recognising innovative practice demonstrating quality in diabetes care.

(Source: Dept of Health & Social Care)

Learning and events

Introduction to continuous glucose monitoring for secondary care healthcare professionals

Free evening webinar for members and non-members
(Thurs. 11 September).

(Source: Royal College of Nursing)

GIRFT Community and District Nurse Insulin Programme (CADNIP)

Free webinar on GIRFT’s programme to support people to receive their prescribed insulin at the right time, in the right amount and in the right way. (1:00–1:45 pm, 24 September)

(Source: NHS England)

Diabetes UK Professional Conference 2026 – abstracts

Abstract submissions are invited for next year’s conference.

(Source: Diabetes UK)

Public health

Hypo Awareness Week 2025

Promoting discussion of hypoglycaemia in hospitals and primary care settings (6–12 October).

(Source: Hypo Awareness Week)

Tackling Inequity Strategy

Diabetes UK’s 5-year strategy to address disparities in care that affect some communities.

(Source: Diabetes UK)

World Diabetes Day

Get involved in raising awareness of the challenges of diabetes and prioritising well-being in the workplace.ear’s conference.

(Source: International Diabetes Federation)

Journals: Articles

The Lancet Series on early-onset type 2 diabetes

Three-part series on emerging evidence on the epidemiology, pathophysiology and management of this condition. [Requires registration]

(Source: The Lancet)

Improving diabetes and pre‑diabetes detection in the UK: Insights From HbA1c screening in an acute hospital’s emergency department

Routine HbA_1c screening , with FINDRISC scoring, successfully identifies individuals with diabetes and pre-diabetes. [Open access]

(Source: Diabetes Therapy)

Type 2 diabetes, prediabetes, and MASLD: who and when to screen and how to treat?

Outline of the current consensus and progress in this field.

(Source: The Lancet Diabetes & Endocrinology)

Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials

Latest evidence on the effectiveness of different fasting strategies. [Open access]

(Source: BMJ)

Type 2 diabetes risk communication following a diagnosis of gestational diabetes mellitus: A qualitative study

Women desire improved risk communication and greater support to understand and reduce their type 2 diabetes risk following GDM. [Open access]

(Source: Diabetic Medicine)

Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohorts1 receptor agonists and body habitus: A systematic review and meta-analysis

Study providing an evidence base for identifying those at risk of DFUD. [Open access]

(Source: Diabetes, Obesity & Metabolism)

Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study

Diabetes sub-type found in children and young adults in sub-Saharan Africa, and may exist in Black individuals elsewhere. [Open access]

(Source: The Lancet Diabetes & Endocrinology)

SARS-CoV-2 infection and new-onset type 1 diabetes in the post-acute period among children and young people in England

SARS-CoV-2 infection associated with subsequent incident type 1 diabetes in previously healthy CYP. [Open access]

(Source: Diabetic Medicine)

A review of the safety of sodium-glucose co-transporter-2 inhibitors

A summary of the evidence and practical advice to promote safer use. [Open access]

(Source: Diabetes, Obesity & Metabolism)

The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus study

Consensus-based clinical recommendations on SGLT2i use in those with diabetic foot disease. [Open access]

(Source: Diabetes, Obesity & Metabolism)

Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

Real-world findings on the effects of tirzepatide on diabetic retinopathy in people with type 2 diabetes.[Open access]

(Source: Diabetologia)

Treating sarcopenic obesity in the era of incretin therapies: Perspectives and challenges

Latest thinking on the safe and effective use of incretins in this group. [Open access]

(Source: Diabetes)

Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial

Study of the potential effects of tirzepatide on muscle health. [Open access]

(Source: The Lancet Diabetes & Endocrinology)

Risk of thyroid tumors with GLP-1 receptor agonists: A retrospective cohort study

No significant increased risk of thyroid tumours compared with other therapies. [Open access]

(Source: Diabetes Care)

Journals: Quick reads

At a glance: Diabetes and dementia

The relationships between diabetes, cognitive decline and dementia, and the consequences of dementia for the management of diabetes. [Open access]

(Source: Diabetes & Primary Care)

Prescribing pearls: Finerenone for managing CKD in type 2 diabetes

Indications, effects and prescribing tips for this non-steroidal selective MRA. [Open access]

(Source: Diabetes & Primary Care)

Diabetes Distilled: Maternal diabetes associated with increased risk of neuro-development disorders in children

Risk ratios of 1.25 for autism spectrum disorder and 1.30 for ADHD observed in offspring of mothers with diabetes in pregnancy. [Open access]

(Source: Diabetes & Primary Care)

Diabetes Distilled: Weight loss – is it quantity or quality that matters?

Consider outcomes beyond the degree of weight loss to prioritise when discussing weight management options. [Open access]

(Source: Diabetes & Primary Care)

Health literacy is much more than knowing about health; it also involves the emotions experienced during illness

Addressing emotional, cognitive and social dimensions to improve diabetes care and quality of life. [Open access]

(Source: PLOS Digital Health)

Highlights from the 85^th Scientific Sessions of the American Diabetes Association

Key presentations from a diabetes nursing perspective, including developments in the pharmaceutical realm.
[Open access]

(Source: Journal of Diabetes Nursing)

Resources

How to approach and manage diabetes in people with dementia

Principles of care for people with diabetes and co-morbid dementia.

(Source: Diabetes & Primary Care)

MHRA approves licensing for teplizumab to be used in the UK

First disease-modifying therapy for type 1 diabetes licensed in the UK.

(Source: Breakthrough T1D)

Oxford Handbook of Diabetes Nursing (2^nd edition)

New edition providing education for the holistic and gold standard of care for all adults living with diabetes.

(Source: Oxford Academic)

Patient resources

I am taking a GLP-1 weight-loss medication – what should I know?

Diet and exercise advice for patients taking GLP-1medications. 

(Source: JAMA Internal Medicine)

Emotional Wellbeing

New course to help people understand the connection between their diabetes and how they feel emotionally.

(Source: Diabetes UK)